✦ LIBER ✦

Moclobemide versus fluoxetine for a major depressive episode

✍ Scribed by C. Reynaert; P. Janne; M. Parent; J. Mirel; L. Hazzen

Publisher: Springer
Year: 1995
Tongue: English
Weight: 550 KB
Volume: 118
Category: Article
ISSN: 0033-3158
DOI: 10.1007/bf02245838

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fluvoxamine versus fluoxetine in major d

Fluvoxamine versus fluoxetine in major depressive episode: a double-blind randomised comparison

✍ Jean Dalery; Adriaan Honig 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

## Abstract A double‐blind, multinational study was conducted to compare the efficacy and safety of fluvoxamine and fluoxetine in outpatients with major depressive episode; 184 patients were randomised to fluvoxamine (100 mg/day) or fluoxetine (20 mg/day) for 6 weeks. Both drugs were effective and

Recovery from a recurrent major depressi

Recovery from a recurrent major depressive episode

✍ Howard M. Kravitz; Robert W. Bloom; Jan Fawcett 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB

Marijuana use and the risk of Major Depr

Marijuana use and the risk of Major Depressive Episode

✍ Chuan-Yu Chen; Fernando A. Wagner; James C. Anthony 📂 Article 📅 2002 🏛 Springer-Verlag 🌐 English ⚖ 256 KB

Moclobemide and placebo in mild major de

Moclobemide and placebo in mild major depression: a double-blind randomized trial

✍ E. Ose; P. Holm 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 137 KB

A double-blind comparison of moclobemide

A double-blind comparison of moclobemide and toloxatone in out-patients presenting a major depressive disorder

✍ P. Lemoine; C. Mirabaud 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 134 KB

Long-term treatment with moclobemide. An

Long-term treatment with moclobemide. An open-label, non-comparative, multiple-distributed study in patients with a major depressive episode as defined by DSM-III

✍ E. Moll; M. Stabl; R. Wegscheider; R. Amrein 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 297 KB